LTS joins UN Global Compact network
LTS is a member of the UN Global Compact Network, the world’s largest initiative for sustainable and responsible corporate leadership.
Advancing biologics and vaccine delivery with Microneedle Array Patch (MAP) Technology
In our webcast Dr. May Pidding explains how clinically needs-driven [...]
LTS Webinar: Advancing Biologics and Vaccine Delivery with Microneedle Array Patch Technology
On March 5 at 13:00 CST (China) LTS, in collaboration with Ouryao, will host a live online webinar focused on development strategies and microneedle technologies for formulations target to deliver small molecules, biologics and vaccines.
LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
Andernach and Montreal – LTS LOHMANN Therapie-Systeme AG (LTS), a [...]
LTS Receives Grant to Support Women’s Health in LIMICs
LTS is pleased to announce that it has received a grant of $592,454.00 from the Gates Foundation.
LTS Receives Best Managed Companies Award 2025
LTS has been honored with the Best Managed Companies Award [...]
The innovation behind Flexeon
Following the launch of FLEXEON we caught up with Regina Graf, a scientist to find out more about our latest gamechanger offer.
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
LTS LOHMANN Therapie-Systeme AG is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize.
Interview with Slawa Troubniakov, Head of Sustainability
Across our diverse portfolio of drug delivery technologies, innovation is motivated by the idea of achieving optimal benefit for patients and our partners.
The LTS Christmas Market 2024
Our employees were able to enjoy the Christmas Market and donate for our charity partners: Hoffnungswerk and Hospizverein Koblenz.